A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?

There is no question that incretin-based glucose-lowering medications have proven to be effective glucose-lowering agents. Glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate an efficacy comparable to insulin treatment and appear to do so with significant effects to promote weight loss wit...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Butler, Peter C., Elashoff, Michael, Elashoff, Robert, Gale, Edwin A.M.
Format: Artigo
Sprog:Inglês
Udgivet: American Diabetes Association 2013
Fag:
Point-Counterpoint
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687282/
https://ncbi.nlm.nih.gov/pubmed/23645885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2713
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker